Global Stem Cell Banking Market 2018-2022

Detailed TOC of Global Stem Cell Banking Market 2018-2022

Table of Contents
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis
PART 05: MARKET SIZING
• Market definition
• Market sizing 2017
• Market size and forecast
PART 06: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition
PART 07: MARKET SEGMENTATION BY CELL TYPE
• Overview
• Comparison by cell type
• Adult stem cells
• Umbilical cord blood stem cells
• Embryonic stem cells
• Market opportunity by cell type
PART 08: CUSTOMER LANDSCAPE
PART 09: REGIONAL LANDSCAPE
• Geographical segmentation
• Regional comparison
• Stem cell banking market in Americas
• Stem cell banking market in EMEA
• Stem cell banking market in APAC
• Market opportunity
PART 10: DECISION FRAMEWORK
PART 11: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges
PART 12: MARKET TRENDS
• Increasing implementation of inorganic growth strategies
• Rising demand for personalized medicines
• Growing acceptance of stem cell therapies
PART 13: VENDOR LANDSCAPE
• Competitive scenario
PART 14: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• AMAG Pharmaceuticals
• Cordlife
• Cryo-Cell International
• Esperite
• Other prominent vendors
PART 15: APPENDIX
• List of abbreviations
List of Exhibits 
Exhibit 01: Global stem cell banking market: Related market
Exhibit 02: Global stem cell banking market: Market characteristics
Exhibit 03: Global stem cell banking market: Market segments
Exhibit 04: Market definition: Inclusions and exclusions checklist
Exhibit 05: Global stem cell banking market: Market size 2017
Exhibit 06: Validation techniques employed for market sizing 2017
Exhibit 07: Global stem cell banking market: Market size and forecast 2017-2022 ($ billions)
Exhibit 08: Global stem cell banking market: Year-over-year growth 2017-2022 (%)
Exhibit 09: Five forces analysis 2017
Exhibit 10: Five forces analysis 2022
Exhibit 11: Bargaining power of suppliers
Exhibit 12: Threat of new entrants
Exhibit 13: Threat of substitutes
Exhibit 14: Threat of rivalry
Exhibit 15: Market condition: Five forces 2017
Exhibit 16: Market condition: Five forces 2022
Exhibit 17: Global stem cell banking market: Segmentation by cell type 2017-2022 (% share)
Exhibit 18: Global stem cell banking market: Comparison by cell type
Exhibit 19: Global adult stem cell banking market 2017-2022 ($ billions)
Exhibit 20: Global adult stem cell banking market: Year-over-year growth 2018-2022 (%)
Exhibit 21: Global umbilical cord blood stem cell banking market 2017-2022 ($ billions)
Exhibit 22: Global umbilical cord blood stem cell banking market: Year-over-year growth 2018-2022 (%)
Exhibit 23: Global embryonic stem cell banking market 2017-2022 ($ billions)
Exhibit 24: Global embryonic stem cell banking market: Year-over-year growth 2018-2022 (%)
Exhibit 25: Global stem cell banking market: Market opportunity by cell type
Exhibit 26: Global stem cell banking market: Customer landscape
Exhibit 27: Global stem cell banking market: Segmentation by geography 2017-2022 (% share)
Exhibit 28: Regional comparison
Exhibit 29: Stem cell banking market in Americas 2017-2022 ($ billions)
Exhibit 30: Stem cell banking market in Americas: Year-over-year growth 2018-2022 (%)
Exhibit 31: Top three countries in Americas
Exhibit 32: Stem cell banking market in EMEA 2017-2022 ($ billions)
Exhibit 33: Stem cell banking market in EMEA: Year-over-year growth 2018-2022 (%)
Exhibit 34: Top three countries in EMEA
Exhibit 35: Stem cell banking market in APAC 2017-2022 ($ billions)
Exhibit 36: Stem cell banking market in APAC: Year-over-year growth 2018-2022 (%)
Exhibit 37: Top three countries in APAC
Exhibit 38: Cancer severity across EU in 2013 and cancer incidence in US in 2014
Exhibit 39: Year-over-Year growth and growth rate of stem cell research spending in US 2013-2016 ($ billions)
Exhibit 40: CIRM funding in stem cell research 2014 ($ billions)
Exhibit 41: CIRM active programs 2014
Exhibit 42: EC funding for regenerative medicine
Exhibit 43: Strategic success factors of vendors in market
Exhibit 44: Vendor classification
Exhibit 45: Market positioning of vendors
Exhibit 46: AMAG Pharmaceuticals: Overview
Exhibit 47: AMAG Pharmaceuticals: Business segments
Exhibit 48: AMAG Pharmaceuticals: Organizational developments
Exhibit 49: AMAG Pharmaceuticals: Geographic focus
Exhibit 50: AMAG Pharmaceuticals: Segment focus
Exhibit 51: AMAG Pharmaceuticals: Key offerings
Exhibit 52: Cordlife: Overview
Exhibit 53: Cordlife: Business segments
Exhibit 54: Cordlife: Organizational developments
Exhibit 55: Cordlife: Geographic focus
Exhibit 56: Cordlife: Segment focus
Exhibit 57: Cordlife: Key offerings
Exhibit 58: Cryo-Cell International: Overview
Exhibit 59: Cryo-Cell International: Business segments
Exhibit 60: Cryo-Cell International: Organizational developments
Exhibit 61: Cryo-Cell International: Geographic focus
Exhibit 62: Cryo-Cell International: Segment focus
Exhibit 63: Cryo-Cell International: Key offerings
Exhibit 64: Esperite: Overview
Exhibit 65: Esperite: Business segments
Exhibit 66: Esperite: Organizational developments
Exhibit 67: Esperite: Geographic focus
Exhibit 68: Esperite: Segment focus
Exhibit 69: Esperite: Key offerings